Immune checkpoint blockades therapy of melanoma

. 2023 Feb 26;68(4):356-358.

doi: 10.1016/j.scib.2023.02.003. Epub 2023 Feb 2.

Affiliations

¹ Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha 410008, China. Electronic address: hongliu1014@csu.edu.cn.
² Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha 410008, China.
³ Graduate Institute of Biomedical Sciences, Research Center for Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung 40402, Taiwan, China; Department of Biotechnology, Asia University, Taichung 41354, Taiwan, China; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA.
⁴ Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha 410008, China. Electronic address: chenxiangck@126.com.

Hong Liu et al. Sci Bull (Beijing). 2023.

. 2023 Feb 26;68(4):356-358.

doi: 10.1016/j.scib.2023.02.003. Epub 2023 Feb 2.

¹ Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha 410008, China. Electronic address: hongliu1014@csu.edu.cn.
² Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha 410008, China.
³ Graduate Institute of Biomedical Sciences, Research Center for Cancer Biology and Center for Molecular Medicine, China Medical University, Taichung 40402, Taiwan, China; Department of Biotechnology, Asia University, Taichung 41354, Taiwan, China; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA.
⁴ Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha 410008, China. Electronic address: chenxiangck@126.com.

No abstract available

Conflict of interest statement

Conflict of interest The authors declare that they have no conflict of interest.